Latest papers

Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection.

Plasma biomarker screening for liver fibrosis with the N-terminal isotope tagging strategy.

Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis.

Autophagy in nonalcoholic steatohepatitis.

IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma.

Long-Term Outcome After Antiviral Therapy of Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis

Inconsistency in the management of patients with hepatocellular carcinoma: the need for a strict protocol.

Cost-effective analysis of transjugular intrahepatic portosystemic shunt versus surgical portacaval shunt for variceal bleeding in early cirrhosis.

A laparoscopic splenectomy allows the induction of antiviral therapy for patients with cirrhosis associated with hepatitis C virus.

Relationship between portal chronic inflammation and disease severity in paediatric non-alcoholic fatty liver disease.

Summaries for patients: Screening for liver cancer in patients with hepatitis C virus infection and cirrhosis.

[A differentiated approach to the diagnosis and treatment of portal hypertension in children].

Adjuvant therapy after curative treatment for hepatocellular carcinoma.

Factors associated with liver fibrosis in intravenous drug users coinfected with HIV and HCV.

[Fatty liver and its clinical management in obese adolescents].

Early virological response in 1220 patients with HCV (genotype lb) chronic hepatitis and cirrhosis treated with PegInterferon plus Ribavirin.

[Pathogenetic mechanisms and morphological manifestations of medical liver damage].

Impact of immunosuppressive therapy on hepatitis C infection after renal transplantation.

Chronic hepatitis B in Asia-new insights from the past decade.

EMR2 receptor ligation modulates cytokine secretion profiles and cell survival of lipopolysaccharide-treated neutrophils.